Company Filing History:
Years Active: 1987-1988
Title: Inventor Spotlight: Eugene McPherson
Introduction
Eugene McPherson, an accomplished inventor based in Forestville, MD (US), has made significant contributions to the field of pharmaceuticals with his innovative approach to medicinal chemistry. With a total of two patents to his name, McPherson’s work focuses on developing compounds that exhibit antibacterial and antitumor properties.
Latest Patents
Among his latest inventions is a patent for "1a-7-substituted derivatives of mitomycin and uses thereof." This invention reveals 1a- and 7-substituted derivatives of mitosanes that contain thiocarbamoyl and glycosyl residues. These compounds demonstrate promising antibacterial and antitumor activity while showcasing a reduction in bone marrow toxicity compared to their parent compounds. Additionally, he holds a patent for "Galactose-C-6 nitrogen mustard compounds and their uses." This patent outlines compounds characterized by a specific formula, detailing various chemical groups and configurations, along with their methods of synthesis and application in pharmaceutical formulations.
Career Highlights
Eugene McPherson is associated with Georgetown University, where he conducts his research and contributes to the academic community. His work in inventing novel chemical compounds underscores his expertise and commitment to advancing healthcare solutions through innovative research.
Collaborations
In his endeavors, McPherson collaborates with renowned scientist Philip S. Schein, emphasizing the importance of teamwork and interdisciplinary approaches in the field of medicinal chemistry. Their partnership highlights the potential for groundbreaking discoveries in developing effective therapeutic agents.
Conclusion
Eugene McPherson is a notable inventor whose contributions to the field of pharmaceuticals reflect a dedication to improving therapeutic options for patients. His innovative patented compounds hold promise in addressing diseases while minimizing adverse effects, and his collaborative efforts further enhance the potential for future advancements in medicinal chemistry.